Stock Research for NVO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NVO Stock Chart & Research Data

The NVO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NVO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NVO Due diligence Resources & Stock Charts

The NVO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NVO Detailed Price Forecast - CNN Money CNN View NVO Detailed Summary - Google Finance
Yahoo View NVO Detailed Summary - Yahoo! Finance Zacks View NVO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NVO Trends & Analysis - Trade-Ideas Barrons View NVO Major Holders - Barrons
NASDAQ View NVO Call Transcripts - NASDAQ Seeking View NVO Breaking News & Analysis - Seeking Alpha
Spotlight View NVO Annual Report - CompanySpotlight.com OTC Report View NVO OTC Short Report - OTCShortReport.com
TradeKing View NVO Fundamentals - TradeKing Charts View NVO SEC Filings - Bar Chart
WSJ View Historical Prices for NVO - The WSJ Morningstar View Performance/Total Return for NVO - Morningstar
MarketWatch View the Analyst Estimates for NVO - MarketWatch CNBC View the Earnings History for NVO - CNBC
StockMarketWatch View the NVO Earnings - StockMarketWatch MacroAxis View NVO Buy or Sell Recommendations - MacroAxis
Bullish View the NVO Bullish Patterns - American Bulls Short Pains View NVO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NVO Stock Mentions - StockTwits PennyStocks View NVO Stock Mentions - PennyStockTweets
Twitter View NVO Stock Mentions - Twitter Invest Hub View NVO Investment Forum News - Investor Hub
Yahoo View NVO Stock Mentions - Yahoo! Message Board Seeking Alpha View NVO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NVO - SECform4.com Insider Cow View Insider Transactions for NVO - Insider Cow
CNBC View NVO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NVO - OTC Markets
Yahoo View Insider Transactions for NVO - Yahoo! Finance NASDAQ View Institutional Holdings for NVO - NASDAQ


Stock Charts

FinViz View NVO Stock Insight & Charts - FinViz.com StockCharts View NVO Investment Charts - StockCharts.com
BarChart View NVO Stock Overview & Charts - BarChart Trading View View NVO User Generated Charts - Trading View




Latest Financial News for NVO


Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus
Posted on Friday September 21, 2018

Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus


Novo Nordisk to Restructure R&D Unit & Lay Off 400 Staff
Posted on Wednesday September 19, 2018

Novo Nordisk (NVO) plans to restructure and reallocate resources in its Research and Development organization and lay off 400 employees from the unit.


Danish pharma giant Novo Nordisk to open first Mass. office
Posted on Tuesday September 18, 2018

Of the world's 20 largest drugmakers, 17 have a presence in Massachusetts. Novo Nordisk has been one of the three outliers — until now.


Novo Nordisk lays off 400 staff in research & development unit
Posted on Tuesday September 18, 2018

Novo Nordisk, the world's top maker of diabetes drugs, said on Tuesday that it will lay off 400 staff in Denmark and China as part of a broader restructuring of its research and development organisation. Novo Nordisk said in May that new U.S. legislation aimed at reining in high drug prices would cut its 2019 sales by 1-2 percent. It announced 1,000 job cuts in 2016 as competition among insulin producers increased and prices were squeezed by pharmacy benefit managers (PBMs) who administer drug programs for employers and health plans.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.